Clinical Trial Update: Dexamethasone Regimens for BPD Prevention in Preterm Infants [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating dexamethasone regimens to prevent bronchopulmonary dysplasia in premature infants, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Infant, Premature, Bronchopulmonary Dysplasia (BPD) | Phase 3 | Status: NOT_YET_RECRUITING